406 related articles for article (PubMed ID: 23918355)
21. Chemical Reversion of Conventional Human Pluripotent Stem Cells to a Naïve-like State with Improved Multilineage Differentiation Potency.
Park TS; Zimmerlin L; Evans-Moses R; Zambidis ET
J Vis Exp; 2018 Jun; (136):. PubMed ID: 29939183
[TBL] [Abstract][Full Text] [Related]
22. Teratoma formation of human embryonic stem cells in three-dimensional perfusion culture bioreactors.
Stachelscheid H; Wulf-Goldenberg A; Eckert K; Jensen J; Edsbagge J; Björquist P; Rivero M; Strehl R; Jozefczuk J; Prigione A; Adjaye J; Urbaniak T; Bussmann P; Zeilinger K; Gerlach JC
J Tissue Eng Regen Med; 2013 Sep; 7(9):729-41. PubMed ID: 22438087
[TBL] [Abstract][Full Text] [Related]
23. Reversible transformation and de-differentiation of human cells derived from induced pluripotent stem cell teratomas.
Kamada M; Mitsui Y; Matsuo T; Takahashi T
Hum Cell; 2016 Jan; 29(1):1-9. PubMed ID: 26069211
[TBL] [Abstract][Full Text] [Related]
24. A new class of pluripotent stem cell cytotoxic small molecules.
Richards M; Phoon CW; Goh GT; Seng EK; Guo XM; Tan CM; Chan WK; Lee JM
PLoS One; 2014; 9(3):e85039. PubMed ID: 24647085
[TBL] [Abstract][Full Text] [Related]
25. Structure-Activity Relationship Analysis of YM155 for Inducing Selective Cell Death of Human Pluripotent Stem Cells.
Go YH; Lim C; Jeong HC; Kwon OS; Chung S; Lee H; Kim W; Suh YG; Son WS; Lee MO; Cha HJ; Kim SH
Front Chem; 2019; 7():298. PubMed ID: 31157201
[TBL] [Abstract][Full Text] [Related]
26. Identification of specific pluripotent stem cell death--inducing small molecules by chemical screening.
Conesa C; Doss MX; Antzelevitch C; Sachinidis A; Sancho J; Carrodeguas JA
Stem Cell Rev Rep; 2012 Mar; 8(1):116-27. PubMed ID: 21617963
[TBL] [Abstract][Full Text] [Related]
27. Dioxonaphthoimidazoliums are Potent and Selective Rogue Stem Cell Clearing Agents with SOX2-Suppressing Properties.
Ho SH; Ali A; Ng YC; Lam KK; Wang S; Chan WK; Chin TM; Go ML
ChemMedChem; 2016 Sep; 11(17):1944-55. PubMed ID: 27444266
[TBL] [Abstract][Full Text] [Related]
28. STB-HO, a novel mica fine particle, inhibits the teratoma-forming ability of human embryonic stem cells after in vivo transplantation.
Choi SW; Shin TH; Uddin MH; Shin JH; Kang TW; Lee BC; Kim HS; Seo Y; Shams S; Jung YK; Kang KS
Oncotarget; 2016 Jan; 7(3):2684-95. PubMed ID: 26646796
[TBL] [Abstract][Full Text] [Related]
29. Design of a Vitronectin-Based Recombinant Protein as a Defined Substrate for Differentiation of Human Pluripotent Stem Cells into Hepatocyte-Like Cells.
Nagaoka M; Kobayashi M; Kawai C; Mallanna SK; Duncan SA
PLoS One; 2015; 10(8):e0136350. PubMed ID: 26308339
[TBL] [Abstract][Full Text] [Related]
30. Selective elimination of human pluripotent stem cells by an oleate synthesis inhibitor discovered in a high-throughput screen.
Ben-David U; Gan QF; Golan-Lev T; Arora P; Yanuka O; Oren YS; Leikin-Frenkel A; Graf M; Garippa R; Boehringer M; Gromo G; Benvenisty N
Cell Stem Cell; 2013 Feb; 12(2):167-79. PubMed ID: 23318055
[TBL] [Abstract][Full Text] [Related]
31. An Ethanol Extract of
Kim A; Baek SJ; Shin S; Lee SY; Chung SK
Nutrients; 2023 May; 15(10):. PubMed ID: 37242247
[TBL] [Abstract][Full Text] [Related]
32. Defining the nature of human pluripotent stem cell progeny.
Patterson M; Chan DN; Ha I; Case D; Cui Y; Van Handel B; Mikkola HK; Lowry WE
Cell Res; 2012 Jan; 22(1):178-93. PubMed ID: 21844894
[TBL] [Abstract][Full Text] [Related]
33. Regulation of cyclin E1 expression in human pluripotent stem cells and derived neural progeny.
Rodríguez Varela MS; Mucci S; Videla Richardson GA; Morris Hanon O; Furmento VA; Miriuka SG; Sevlever GE; Scassa ME; Romorini L
Cell Cycle; 2018; 17(14):1721-1744. PubMed ID: 29995582
[TBL] [Abstract][Full Text] [Related]
34. Rapid, efficient, and simple motor neuron differentiation from human pluripotent stem cells.
Shimojo D; Onodera K; Doi-Torii Y; Ishihara Y; Hattori C; Miwa Y; Tanaka S; Okada R; Ohyama M; Shoji M; Nakanishi A; Doyu M; Okano H; Okada Y
Mol Brain; 2015 Dec; 8(1):79. PubMed ID: 26626025
[TBL] [Abstract][Full Text] [Related]
35. Prediction of Differentiation Tendency Toward Hepatocytes from Gene Expression in Undifferentiated Human Pluripotent Stem Cells.
Yanagihara K; Liu Y; Kanie K; Takayama K; Kokunugi M; Hirata M; Fukuda T; Suga M; Nikawa H; Mizuguchi H; Kato R; Furue MK
Stem Cells Dev; 2016 Dec; 25(24):1884-1897. PubMed ID: 27733097
[TBL] [Abstract][Full Text] [Related]
36. Selective apoptosis of pluripotent mouse and human stem cells by novel ceramide analogues prevents teratoma formation and enriches for neural precursors in ES cell-derived neural transplants.
Bieberich E; Silva J; Wang G; Krishnamurthy K; Condie BG
J Cell Biol; 2004 Nov; 167(4):723-34. PubMed ID: 15545317
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of an NAD⁺ salvage pathway provides efficient and selective toxicity to human pluripotent stem cells.
Kropp EM; Oleson BJ; Broniowska KA; Bhattacharya S; Chadwick AC; Diers AR; Hu Q; Sahoo D; Hogg N; Boheler KR; Corbett JA; Gundry RL
Stem Cells Transl Med; 2015 May; 4(5):483-93. PubMed ID: 25834119
[TBL] [Abstract][Full Text] [Related]
38. Elimination of undifferentiated human embryonic stem cells by cardiac glycosides.
Lin YT; Wang CK; Yang SC; Hsu SC; Lin H; Chang FP; Kuo TC; Shen CN; Chiang PM; Hsiao M; Lu FL; Lu J
Sci Rep; 2017 Jul; 7(1):5289. PubMed ID: 28706279
[TBL] [Abstract][Full Text] [Related]
39. Repair of Ischemic Injury by Pluripotent Stem Cell Based Cell Therapy without Teratoma through Selective Photosensitivity.
Cho SJ; Kim SY; Jeong HC; Cheong H; Kim D; Park SJ; Choi JJ; Kim H; Chung HM; Moon SH; Cha HJ
Stem Cell Reports; 2015 Dec; 5(6):1067-1080. PubMed ID: 26584542
[TBL] [Abstract][Full Text] [Related]
40. Brief reports: Controlling the survival of human pluripotent stem cells by small molecule-based targeting of topoisomerase II alpha.
Ben-David U; Cowell IG; Austin CA; Benvenisty N
Stem Cells; 2015 Mar; 33(3):1013-9. PubMed ID: 25377277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
